Gates Package — page 481

of ssion Bill & Melinda Gates Foundation- National Institutes of Health Third Annual Consultative Workshop April 18, 2016 John Edward Porter Neuroscience Research Center Building 35A, Room 620/630 NIH Campus, Bethesda, Maryland 8:30 A.M. - 8:35 A.M. Welcome Francis S. Collins, MD, PhD, Director, National Institutes of Health (NIH) Trevor Mundel, MD, PhD, President, Global Health Division, Bill & Melinda Gates Foundation (BMGF) 8:35 A.M. - 8:45 A.M. Opening Remarks Bill Gates, Co-Chair and Trustee, Bill & Melinda Gates Foundation 8:45 A.M. - 9:35 A.M. Panel 1: The Research Response to Zika Virus and Research Preparedness for Future Microbial Outbreaks Moderator: Anthony S. Fauci, MD, Director, National Institute of Allergy and Infectious Diseases (NIAID), NIH Discussants Cristina Cassetti, PhD, Translational Science Program Director, Virology Branch, NIAID, NIH Stephen S. Whitehead, PhD, Senior Associate Scientist in the Laboratory of Infectious Diseases, NIAID, NIH Catherine Y. Spong, MD, Acting Director, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH Chris Wilson, MD, Senior Advisor, Global Health Discovery & Translational Sciences, BMGF Steve Kern, PhD, Deputy Director, Quantitative Sciences, BMGF Discussion to include: • Status of basic research on ZIKV pathogenesis and transmission • Status of research on ZIKV as a cause of birth defects • Development of diagnostic tools, treatments and vaccines • Research preparedness for future microbial outbreaks; e.g., real-time genomic sequencing and other capacities • Industrial incentives to develop pandemic preventive vaccines and requirements for effective collaboration